Long-term outcome in BRAFV600E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression

Igor Puzanov, Ravi K. Amaravadi, Grant A. McArthur, Keith T. Flaherty, Paul B. Chapman, Jeffrey A. Sosman, Antoni Ribas, Mark Shackleton, Patrick Hwu, Bartosz Chmielowski, Keith B. Nolop, Paul S. Lin, Kevin B. Kim*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term outcome in BRAF<sup>V600E</sup> melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression'. Together they form a unique fingerprint.

Medicine & Life Sciences